The Cooper Companies
This article was originally published in The Gray Sheet
Executive Summary
Senior VP-operations Thomas Bender named executive vice president and acting chief operating officer. In the latter position, he will assume the duties of current COO Steven Singer, who is on a leave of absence. Singer is among the defendants named in a civil suit filed by the Securities and Exchange Commission in November 1992 alleging participation in an illegal junk bond trading scheme ("The Gray Sheet" Nov. 16, 1992, p. 16). Also elected to the company's board of directors, Bender will continue to serve as president and chief executive officer for the company's contact lens subsidiary CooperVision, positions he has held since 1991
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.